Biological Matrix Supply Chain Shortages: More Matrices Are Now Rare—the Case for Surrogate Matrices

The COVID-19 pandemic has strained the biological matrix supply chain. An upsurge in demand driven by numerous COVID-19 therapeutic and vaccine development programs to combat the pandemic, along with logistical challenges sourcing and transporting matrix, has led to increased lead times for multiple...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubiel, Evan A., Myler, Heather, Arnold, Mark E., Bennett, Patrick, Gatz, Jeff, Groeber, Elizabeth, Gupta, Seema, Kane, Cheikh, Li, Fumin, Mylott, William, Noah, Courtney, O’Dell, Mark, Tewalt, Eric, Warrino, Dominic, Vick, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920421/
https://www.ncbi.nlm.nih.gov/pubmed/35288790
http://dx.doi.org/10.1208/s12248-022-00694-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920421/
https://www.ncbi.nlm.nih.gov/pubmed/35288790
http://dx.doi.org/10.1208/s12248-022-00694-1

Ejemplares similares